ong-term prognosis of patients with frequently-relapsing / steroid-dependent nephrotic syndrome who participated in JSKDC10 clinical trials

Not Applicable

Recruiting

• Conditions: Frequently-relapsing/ steroid-dependent nephrotic syndrome; nephrotic syndrome; D009404

• Registration Number: JPRN-jRCT1050230024
• Lead Sponsor: ozu Kandai

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-05-21
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patients with frequently-relapsing/steroid-dependent nephrotic syndrome who participated in the JSKDC 10 clinical traials

Exclusion Criteria

Patients who were offered non-participation in this study from publicly available information

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Relapse-free period

Secondary Outcome Measures

Name	Time	Method
(1) Relapse<br>(2) Relapse rate (times/person-year)<br>(3) Progression to frequently-relapsing/steroid-dependent or steroid-resistant nephrotic syndrome<br>(4) Treatment with or without additional immunosuppressants or rituximab<br>(5) Serum IgG level